- Coadministration of mRNA-1345 with seasonal influenza or COVID-19 vaccines showed acceptable safety profiles and mostly noninferior immunogenicity in adults aged 50 years or older.
- No significant safety concerns were revealed, and the reactogenicity profiles of the coadministered regimens were generally similar to the profiles when the vaccines were administered alone.
- Coadministered mRNA-1345 plus SIIV4 or mRNA-1273.214 vaccines had acceptable safety profiles and elicited mostly noninferior immune responses compared with individual vaccines.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
